isoconazole has been researched along with Kaposi Disease in 1 studies
1-{2-[(2,6-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that carries a 2-[(2,6-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 1.
isoconazole : A racemate comprising equimolar amounts of (R)- and (S)-isoconazole. A broad-spectrum antibacterial drug used (as its nitrate salt) for treatment of dermatomycoses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobaisi, F | 1 |
| Sulpice, E | 1 |
| Barette, C | 1 |
| Fayyad, N | 1 |
| Fauvarque, MO | 1 |
| Badran, B | 1 |
| Fayyad-Kazan, M | 1 |
| Fayyad-Kazan, H | 1 |
| Gidrol, X | 1 |
| Rachidi, W | 1 |
1 other study available for isoconazole and Kaposi Disease
| Article | Year |
|---|---|
Isoconazole and Clemizole Hydrochloride Partially Reverse the Xeroderma Pigmentosum C Phenotype.
Topics: Benzimidazoles; Cell Line; Cell Survival; Drug Repositioning; Humans; Miconazole; Skin Diseases; Ult | 2021 |